Federal Register / Vol. 61, No. 98 / Monday, May 20, 1996 / Notices 25229

marketing the product in 1980 because

of liver toxicity observed after approval

of the NDA. SmithKline waived its

opportunity for a hearing.

Therefore, under section 505(e) of the

Federal Food, Drug, and Cosmetic Act

(21 U.S.C. 355(e)) and under authority

delegated to the Director, Center for

Drug Evaluation and Research (21 CFR

5.82), approval of NDA 18–103, and all

amendments and supplements thereto,

is hereby withdrawn effective May 20,

1996.

Dated: May 6, 1996.

Murray M. Lumpkin,

Deputy Director, Center for Drug Evaluation

and Research.

[FR Doc. 96–12570 Filed 5–15–96; 8:45 am]

BILLING CODE 4160–01–F

Health Care Financing Administration

Agency Information Collection

Activities: Proposed Collection;

Comment Request

AGENCY: Health Care Financing

Administration.

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summaries of proposed

collections for public comment.

Interested persons are invited to send

comments regarding this burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

1. Type of Information Collection

Request: New Collection; Title of

Information Collection: Evaluation of

the Oregon Medicaid Reform

Demonstration: Adult Interview, Child

Interview, Pediatric Asthma Interview,

Insulin-Dependent Diabetes Interview,

Low Back Pain Interview, Medical

Provider Questionnaire; Form No.:

HCFA–R–192; Use: The survey

instruments listed above are for use in

the Evaluation of the Oregon Medicaid

Reform Demonstration. The Adult and

Child Interviews are designed to collect

information related to health status,

access to care, satisfaction with care and

past health insurance status for adult

and child members of the Oregon Health

Plan (OHP). The Pediatric Asthma

Interview, Insulin-Dependent Diabetes

Interview and Low Back Pain Interview

collect information on quality of care,

utilization of care, satisfaction with care

and health status of OHP members with

selected ‘‘tracer conditions.’’ The

Medical Provider Questionnaire is

designed to collect information on how

both participating and non-participating

physicians view OHP; Frequency:

Biennially, Other (one time); Affected

Public: Not-for-profit institutions,

individuals and households, business or

other for-profit; Number of

Respondents: 22,229; Total Annual

Hours: 3,070.

2. Type of Information Collection

Request: New Collection; Title of

Information Collection: Evaluation of

the Per-Episode Home Health

Prospective Payment Demonstration;

Form No.: HCFA–R–195; Use: This

evaluation will collect primary data

from samples of patients and from

demonstration agencies to assess

impacts of per-episode payment on

access to care, quality of care, and the

use of non-Medicare services;

Frequency: Other (one time); Affected

Public: Not-for-profit institutions,

individuals and households, business or

other for-profit; Number of

Respondents: 19,191; Total Annual

Hours: 1,901.

3. Type of Information Collection

Request: Extension of a currently

approved collection; Title of

Information Collection: Blood Bank

Inspection Checklist and Report; Form

No.: HCFA–282; Use: The blood bank

inspection checklist instrument is used

by the State agency to record data

collected as part of the survey and

certification process to determine

compliance with the requirement for

blood bank services under Clinical

Laboratory Improvement Amendments;

Frequency: Biennially; Affected Public:

State, local, and tribal government,

business or other for-profit, not-forprofit institutions, federal government;

Number of Respondents: 2,500; Total

Annual Hours: 1,250.

To obtain copies of the supporting

statement for the proposed paperwork

collections referenced above, access

HCFA’s WEB SITE ADDRESS at http://

www.ssa.gov/hcfa/hcfahp2.html, or to

obtain the supporting statement and any

related forms, E-mail your request,

including your address and phone

number, to Paperwork@hcfa.gov, or call

the Reports Clearance Office on (410)

786–1326. Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Financial and Human

Resources, Management Planning and

Analysis Staff, Attention: John Burke,

Room C2–26–17, 7500 Security

Boulevard, Baltimore, Maryland 21244–

1850.

Dated: May 13, 1996.

Kathleen B. Larson,

Director, Management Planning and Analysis

Staff, Office of Financial and Human

Resources, Health Care Financing

Administration.

[FR Doc. 96–12527 Filed 5–17–96; 8:45 am]

BILLING CODE 4120–03–P

National Institutes of Health

National Institute on Deafness and

Other Communication Disorders;

Notice of Closed Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act,

amended (5 United States Code

Appendix 2), notice is hereby given of

the following meeting:

Name of Committee: Communication

Disorders Review Committee.

Date: June 5–7, 1996.

Time: 8 am–5:30 pm, June 5; 8 am–5:30

pm, June 6; 8 am–adjournment, June 7.

Place: Doubletree Hotel, 1750 Rockville

Pike, Rockville MD 20852.

Contact Person: Craig A. Jordan, Ph.D.,

Scientific Review Administrator, NIDCD/

DEA/SRB, EPS Room 400C, 6120 Executive

Boulevard, MSC 7180, Bethesda MD 20892–

7180, 301–496–8683.

Purpose/Agenda: To review and evaluate

grant applications. The meeting will be

closed in accordance with the provisions set

forth in sections 552b(c)(4) and 552b(c)(6),

Title 5, United States Code. The applications

and/or proposals and the discussion could

reveal confidential trade secrets or

commercial property such as patentable

material and personnal information

concerning individuals associated with the

applications and/or proposals, the disclosure

of which could constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program No. 93.173 Biological Research

Related to Deafness and Communication

Disorders)

Dated: May 10, 1996.

Susan K. Feldman,

Committee Management Officer, NIH.

[FR Doc. 96–12503 Filed 5–17–96; 8:45 am]

BILLING CODE 4140–01–M

National Cancer Institute; Notice of

Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as